As of 2025-06-13, the Intrinsic Value of Pulse Biosciences Inc (PLSE) is -4.48 USD. This PLSE valuation is based on the model Peter Lynch Fair Value. With the current market price of 16.18 USD, the upside of Pulse Biosciences Inc is -127.67%.
Based on its market price of 16.18 USD and our intrinsic valuation, Pulse Biosciences Inc (PLSE) is overvalued by 127.67%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -4.48 - -4.48 | -4.48 | -127.67% |
| P/E | (32.36) - (32.65) | (32.69) | -302.0% |
| DDM - Stable | (6.51) - (30.37) | (18.44) | -214.0% |
| DDM - Multi | (5.01) - (19.37) | (8.10) | -150.1% |
| Market Cap (mil) | 1,088.43 |
| Beta | 1.87 |
| Outstanding shares (mil) | 67.27 |
| Enterprise Value (mil) | 969.15 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.14% |
| Cost of Debt | 5.00% |
| WACC | 6.91% |